ABLA
STAA icon

Alan B. Lancz & Associates’s STAAR Surgical STAA Stock Holding History

Alan B. Lancz & Associates’s Portfolio STAA Stock Details STAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,600
Closed -$129K – 181
2022
Q2 		$129K Buy
+1,600
New +$103K 0.13% 178

Other funds holding STAA

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Alan B. Lancz & Associates's STAA Position: Q3 2022 in Review

Alan B. Lancz & Associates sold out of STAAR Surgical (STAA) in Q3 2022, closing a stake of 1,600 shares — an estimated $129K sold.

Alan B. Lancz & Associates first reported a position in STAA in Q2 2022 and held it in 1 quarter. The position peaked at $129K in Q2 2022. 304 funds tracked by Wall St. Rank hold STAA as of Q3 2022.

  • Alan B. Lancz & Associates reported no remaining STAAR Surgical position as of Q3 2022 after selling out during the quarter.
  • Alan B. Lancz & Associates sold 1,600 STAAR Surgical shares in Q3 2022, an estimated $129K.
  • Alan B. Lancz & Associates first reported a position in STAAR Surgical in Q2 2022 and held it in 1 quarter.
  • Alan B. Lancz & Associates's STAAR Surgical position peaked at $129K in Q2 2022.
  • 304 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2022.

Based on Alan B. Lancz & Associates's 13F filing for Q3 2022, filed 9 Nov 2022.